News Release
Diamond Lake Minerals CEO Brian J. Esposito on how tokenization is changing the game for investors
Diamond Lake Minerals Inc
Diamond Lake Minerals Inc (OTC:DLMI) CEO Brian J. Esposito discusses the company's pioneering role in the development of digital assets and SEC-registered security tokens during an interview with Proactive's Stephen Gunnion. Esposito emphasized the potential of tokenization in redefining investing by opening up global markets to real-world assets previously inaccessible to many investors. He highlighted the importance of operating within regulatory frameworks and the benefits of blockchain technology, including enhanced security and transparency for investors. The company aims to be a trusted authority in the tokenization space, offering exceptional assets through security token offerings or similar mechanisms. Esposito also discussed the challenges of traditional investment mechanisms in real estate and other sectors, suggesting that tokenization could democratize access to investment opportunities, creating liquidity and potentially enabling wealth generation for a broader audience. He further explained DLMI's strategic partnership with Avrio Worldwide PBC, a registered market infrastructure provider with a full technology stack, and their approach to creating value through a hybrid model that combines traditional business growth with the opportunities presented by security token offerings. Esposito welcomed regulatory scrutiny to ensure the safety and security of these new technological advances, while also stressing the need to balance regulation with innovation. He concluded by outlining the company's future plans, which include expanding its portfolio of businesses and continuing to establish their position as a leader in the tokenization space. Contact Details Proactive Canada +1 604-688-8158 action@proactiveinvestors.com
March 21, 2024 12:28 PM Eastern Daylight Time
Video
News Release
ECO Animal Health focused on innovation and global expansion as it grows its pipeline
Eco Animal Health Group PLC
ECO Animal Health Group PLC CEO David Hallas joins Proactive's Stephen Gunnion with more on the global animal health company focused on pigs and poultry. Hallas explained the company offers a variety of products aimed at maintaining animal health and treating diseases, particularly respiratory and intestinal issues. While a significant portion of its revenue is attributed to its flagship product, Aivlosin, he said the company maintains a diversified portfolio with operations in over 70 countries, more than 20 products, and around 200 licences for different indications. Hallas highlighted the company's fourth-quarter and full-year 2024 trading performance, driven by increasing demand for its products, especially Aivlosin, which assists in raising healthy animals to meet the global protein demand. The company's growth is notably robust in Brazil, a key protein producer. Hallas clarified that the company's operations and revenue are not overly dependent on China, with over 75% of revenue generated from outside this region. Despite challenges in the Chinese market reported by competitors, Hallas differentiates ECO Animal Health's sector from genetics, emphasizing its focus on animal health and prevention. The company is also expanding its product line with the upcoming launch of vaccine products in 2025, following recent trademark approvals in the EU, UK, and the US. Additionally, ECO Animal Health has initiated a limited share buyback, viewing it as an opportunistic use of funds following property disposals, while still prioritizing investments in innovation and the current business. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
March 21, 2024 12:26 PM Eastern Daylight Time
Video
News Release
CleanTech Lithium reaches milestone with lithium chloride eluate production at pilot plant in Chile
CleanTech Lithium PLC
CleanTech Lithium PLC (AIM:CTL, OTCQX:CTLHF) executive chairman Dr Steve Kesler joins Proactive's Stephen Gunnion after the company successfully produced lithium chloride through its direct lithium extraction process at its pilot plant in Chile. Kesler told Proactive the development marks a crucial milestone, enabling CleanTech Lithium to scale up for a full-scale plant. It is vital for providing engineering data, producing larger quantities of battery-grade lithium for potential off-takers, and demonstrating the viability of the direct lithium extraction process outside of China. CleanTech Lithium aims to produce up to one tonne of battery-grade lithium monthly, positioning itself as a leader in the sector. The company plans to process the lithium concentrate in North America, using technologies from Conductive Energy and Forward Water Technology, to produce battery-grade lithium carbonate. This approach ensures a low carbon footprint and minimal water usage, aligning with the demand for sustainable lithium production. CleanTech Lithium is in discussions with five major groups under non-disclosure agreements (NDAs) for potential off-take partnerships, aiming to finalize agreements post the completion of their pre-feasibility study (PFS), expected in the third quarter. This strategic approach positions CleanTech Lithium strongly in negotiations for off-take agreements and capital financing for construction. Contact Details Proactive UK +44 20 7989 0813 UKEditorial@proactiveinvestors.com
March 21, 2024 12:22 PM Eastern Daylight Time
Video
News Release
NextEnergy Solar hits milestone with Camilla, first standalone energy storage project
NextEnergy Solar Fund Ltd
NextEnergy Capital Investment Director and UK Legal Counsel, Stephen Rosser, discussed the significant achievement of Camilla, the company's first standalone energy storage asset, up and running. Located in Fife, Scotland, near a major substation and amidst a high concentration of wind farms, the 50-megawatt Camilla has already begun operations. This placement allows it to capitalize on the electricity generation volatility from the wind farms, beneficial for energy storage. Rosser highlighted the importance of Camilla's operational success, including being selected by National Grid for balancing services, a testament to the evolving recognition of battery systems in the energy balance mechanism. Additionally, Camilla secured a tier one capacity auction contract for the upcoming winter, enhancing its revenue prospects. Rosser also noted the progress made by National Grid in adapting its systems to better integrate battery storage solutions, a critical step towards displacing fossil fuels in energy balancing. He shared that NextEnergy is considering upgrading Camilla from a one-hour to a two-hour system, reflecting a disciplined approach to capital allocation. Achieving the one gigawatt milestone through Camilla underscores the pivotal role of energy storage in the UK's transition to a low-carbon energy system, emphasizing the symbiotic relationship between renewable generation and energy storage. NextEnergy Solar Fund's distinction as the first solar plus fund in the investment companies space to reach this milestone was also celebrated. Regarding the investment perspective, Rosser addressed the current share price discount to net asset value and outlined strategies to enhance shareholder value, including selling five solar assets to reduce short-term debt and potentially repurchasing shares. The company's focus on a defensive capital structure, emphasizing the reduction of short-term debt amidst a challenging macroeconomic environment, was reiterated. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
March 21, 2024 12:18 PM Eastern Daylight Time
Video
News Release
Touchstone Exploration discusses transformational 2023 and the road ahead
Touchstone Exploration Inc
Touchstone Exploration Inc (AIM:TXP, TSX:TXP, OTC:PBEGF) CEO Paul Baay describes 2023 as a transformational year for the company, emphasizing the significant growth and operational advancements achieved. In an interview with Proactive's Stephen Gunnion, Baay said key 2023 achievements included the completion of facilities and commissioning of production, and the initiation of the 2024 drilling program. The company also secured new bank financing with a Trinidad bank, enhancing its capitalisation for future projects. Operational focuses such as driving down costs and optimising production were highlighted as contributing factors to the company's different outlook at the end of 2023. The fourth quarter saw remarkable growth with a 150% increase in production, averaging 8,500 barrels of oil equivalent per day (BOE/D), thanks to full quarter production from the Coho and Cascadura fields. This resulted in a $10 million cash flow, suggesting a positive financial trajectory. Looking forward to 2024, Touchstone has commenced its drilling program, encountering promising sands at Cascadura and advancing other projects across their portfolio. The company aims for an average production of 9,400 BOE/D, targeting an end-of-year rate of 14,000 BOE/D. Baay expressed confidence in achieving these targets, underpinned by financial flexibility from expanded banking facilities and a strategic focus on high net-back wells and capacity expansion. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
March 21, 2024 12:16 PM Eastern Daylight Time
Video
News Release
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
Immunic Inc
Immunic Inc (NASDAQ:IMUX) Chief Medical Officer Dr Andreas Muehler discusses the complexities of multiple sclerosis (MS) during an interview with Proactive's Stephen Gunnion to mark MS Awareness Month, highlighting the disease's impact, development, and the unmet medical needs of patients. MS, a lifelong autoimmune disease more prevalent in women than men, begins typically in early adulthood. It manifests in various forms, starting with relapsing-remitting MS, characterized by relapses and MRI lesions, affecting 80-85% of patients. Another form, primary progressive MS, occurs in 10-15% of patients, starting with a progressive phase without typical relapses. As the disease advances, Muehler explained that it transitions into secondary progressive MS, marked by a decrease in relapses but an increase in disability, which is a significant concern for patients. Despite the availability of treatments focusing on inflammation, there remains a significant gap in addressing the disability progression, a key area of concern for patients. Muehler introduced Immunic Inc's approach to tackling MS through their drug, vidofludimus calcium (IMU-838), which possesses dual mechanisms: anti-inflammatory and neuroprotective. The neuroprotective aspect, in particular, is believed to address the critical unmet need of slowing disability progression by protecting neurons. This differentiation, especially in progressive MS where current therapies fall short, positions vidofludimus calcium as a promising candidate in the MS treatment landscape. Clinical trials for vidofludimus calcium are underway, with a notable Phase 2 study, CALLIPER, fully enrolled and expected to read out in April 2025. Additionally, Phase 3 studies in relapsing MS are actively recruiting, with outcomes anticipated in 2026. These developments are keenly awaited by the medical community and potential partners, given the drug's potential to significantly impact MS treatment, particularly for forms of the disease currently lacking effective therapies. Contact Details Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com
March 21, 2024 12:14 PM Eastern Daylight Time
Video
News Release
Strategic Minerals and Cornwall Resources secure groundbreaking deal with Duchy of Cornwall
Strategic Minerals PLC
Strategic Minerals PLC (AIM:SML, OTC:SMCDF) executive director Peter Wale and Dennis Rowland, project manager at subsidiary Cornwall Resources, join Proactive's Stephen Gunnion with news of a groundbreaking mineral rights deal with the Duchy of Cornwall, marking a first of its kind in modern times. The agreement enhances the prospects for mining in Cornwall, expanding Cornwall Resources'' mineral rights by four times and covering a wide range of minerals including tin, tungsten, copper, and silver. Rowland, with a background in geology and extensive experience in mining exploration and development, detailed ongoing projects and the strategic importance of the new mineral rights agreement. He highlighted Cornwall Resources' Redmoor project, known for its significant tungsten and copper resources, alongside the potential for further exploration and mining in the region. The agreement, facilitating access to over 60 kilometres of licence areas adjacent to Redmoor, opens up opportunities for exploration in highly prospective areas with a history of productive mining. The next steps involve detailed geological studies and potential drilling programs to assess the mineralization potential. Furthermore, the company is progressing with a Shared Prosperity Fund grant application to support its initiatives. Wale also noted that Strategic Minerals is preparing for additional drilling and exploration activities, leveraging the cash flow from its Cobre operations in New Mexico to fund these projects. The engagement with stakeholders and commitment to environmental and sustainability standards are emphasized, alongside the anticipation of increased news flow and developments in the coming months. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
March 21, 2024 12:12 PM Eastern Daylight Time
Video
News Release
Globe Metals & Mining advances unique Kanyika Niobium Project in Malawi
GLOBE METALS & MINING LIMITED
Globe Metals & Mining Ltd (ASX:GBE) chief operating officer Paul Smith discusses promising developments at the company's Kanyika project in Malawi, highlighting its position as the first significant niobium project in 50 year. The project, known for integrating mining, concentration, and refining processes within Malawi, has shown notable success in niobium recovery through chlorination refining. This method, preferred over traditional acid treatments for its environmental benefits and lower energy consumption, also supports the extraction of rare earth elements as valuable by-products, enhancing the project's economic appeal. The construction of a lab-scale pilot plant, expected to be operational by April, marks a significant milestone, enabling the production of marketing samples for potential off-takers in Europe, Japan, and North America. This development is crucial for securing offtake agreements and advancing towards the commercialization of niobium and tantalum concentrates. The project's phased development strategy aims to minimize initial costs and dilution for shareholders while seeking structured financing options to support its progression. Contact Details Proactive Australia Pty Ltd Proactive Australia Pty Ltd +61 431 597 771 writers.australia@proactiveinvestors.com
March 21, 2024 12:10 PM Eastern Daylight Time
Video
News Release
PainChek leads innovation in AI-based pain assessment
PainChek Ltd
PainChek Ltd (ASX:PCK), a medical device company, is pioneering the use of an app, leveraging artificial intelligence (AI) for pain assessment in vulnerable individuals unable to communicate their pain due to conditions such as dementia, cognitive impairments, or in pre-verbal children. In and interview with Proactive's Stephen Gunnion CEO and managing director Philip Daffas highlighted that PainChek's app is the world's first regulatory-cleared medical device for this purpose. It utilises AI for facial analysis to detect nine micro facial features indicative of pain, assisting carers in aged care and hospitals to document and score the severity of pain. PainChek has achieved a first mover advantage with patents in the US, Europe, Japan, and the UK, protecting its technology until 2038. The company has regulatory clearance in Australia, New Zealand, Canada, the UK, the EU, Singapore, and Malaysia, with ongoing clinical studies in the US aimed at FDA clearance. PainChek reported its fifth consecutive quarter of double-digit growth in the December quarter, with 85,000 licences across 1,400 aged care facilities on three continents. With an annual recurring revenue of around $4 million, the company sees a significant growth opportunity in aged care, home care, and the hospital sector. Key milestones for investors include expansion in regulatory-cleared markets, entry into the US market upon FDA clearance, and the launch of an infant app for pain assessment in the home. Contact Details Proactive Australia Pty Ltd Proactive Australia Pty Ltd +61 431 597 771 writers.australia@proactiveinvestors.com
March 21, 2024 12:07 PM Eastern Daylight Time
Video
